Malignancies of the peritoneal cavity are associated with a dismal prognosis. Systemic
chemotherapy is the gold standard for patients with unresectable peritoneal disease, but its …

Objective Patients with gynecologic cancers experience a very high symptom burden that
has a negative impact on their quality of life. This systematic review aims to identify the …

Background Patient‐reported adverse events (AEs) may be a useful adjunct to clinician‐
assessed AEs for assessing tolerability in early phase, dose‐finding oncology trials …

The incidence of neutropenia in metastatic castration‐resistant prostate cancer (mCRPC)
patients treated with docetaxel has been reported to be lower compared to patients with …

Introduction Intraperitoneal (IP) chemotherapy improves survival in ovarian cancer but its
use has been limited by toxicity with cisplatin-based regimens. The primary objective of this …